Ticker Details
GeneDx Holdings Corp.
IPO Date:	November 2, 2020
Sector:	Healthcare
Industry:	Health Information Services
Market Cap:	$1.95B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$2.01 | 4.81%
Avg Daily Range (30 D):	$2.34 | 4.06%
Avg Daily Range (90 D):	$2.83 | 4.61%

Institutional Daily Volume
Avg Daily Volume:	.31M
Avg Daily Volume (30 D):	.91M
Avg Daily Volume (90 D):	1.01M

Trade Size
Avg Trade Size (Sh.):	47
Avg Trade Size (Sh.) (30 D):	51
Avg Trade Size (Sh.) (90 D):	55

Institutional Trades
Total Institutional Trades:	1,255
Avg Institutional Trade:	$3.37M
Avg Institutional Trade (30 D):	$3.77M
Avg Institutional Trade (90 D):	$3.13M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$5.07M
Avg Closing Trade (30 D):	$6.59M
Avg Closing Trade (90 D):	$5.59M
Avg Closing Volume:	65.91K

News

Jul 9, 2026 @ 3:02 AM ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages G... Source: Rosen Law Firm

Jul 8, 2026 @ 6:48 PM HBSS Investigates Claims Against GeneDx Holdings (... Source: Hagens Berman

Jul 6, 2026 @ 3:02 AM ROSEN, SKILLED INVESTOR COUNSEL, Encourages GeneDx... Source: Rosen Law Firm

Jul 5, 2026 @ 4:50 PM WGS INVESTORS: Robbins Geller Rudman & Dowd LLP An... Source: Robbins Geller Rudman & Dowd Llp

Jul 5, 2026 @ 3:49 PM CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds ... Source: Faruqi & Faruqi, Llp

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-2.66	$-2.16	$-.61
Diluted EPS	$-2.68	$-2.16	$-.61
Revenue	$442.68M	$102.25M	$120.99M
Gross Profit	$307.91M	$68.21M	$84.27M
Net Income / Loss	$-77.81M	$-63.32M	$-17.67M
Operating Income / Loss	$-66M	$-57.47M	$-14.24M
Cost of Revenue	$134.77M	$34.04M	$36.72M
Net Cash Flow	$-5.78M	$-11.07M	$9.03M
PE Ratio

Splits
May 04, 2023	1:33